Catalent Names Zoetis CFO Wetteny Joseph to Lead Pharma and Consumer Health Unit

  • Wetteny Joseph appointed Group President, Pharma and Consumer Health at Catalent, effective November 2, 2026.
  • Joseph succeeds Aris Gennadios, who is leaving after a 24-year tenure at Catalent.
  • Joseph previously served as EVP and CFO at Zoetis and held senior roles at Catalent, including SVP and CFO.
  • He will report directly to CEO Alessandro Maselli and join Catalent’s Group Executive Committee.

Catalent’s appointment of Wetteny Joseph reflects a strategic pivot to leverage his global leadership experience and financial acumen. His background in driving business growth and transformation at Zoetis suggests a focus on operational excellence and value creation. The move comes amid increasing competition in the CDMO space, where scale and strategic investments are critical for sustaining growth.

Strategic Realignment
How Joseph’s experience at Zoetis will influence Catalent’s PCH segment strategy.
Execution Risk
Whether Joseph can sustain the growth trajectory of the PCH business.
Governance Dynamics
The impact of Joseph’s appointment on Catalent’s Group Executive Committee dynamics.